Search research articles
Contact Us
Filters
Showing results (201-210 of 241) with videos related to
Page
of 25
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 22, 2022
[Management of Chronic Kidney Disease in Cancer Survivors]
Chihiro Kondoh, Kenji Ishikura, Satoko Ichioka, et al.
International Journal of Cancer
|
July 9, 2020
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
Yoshihiro Nishida, Hiroshi Urakawa, Robert Nakayama, et al.
Cancer Science
|
April 3, 2008
CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
Ken-ichi Fujita, Wataru Yamamoto, Shoji Endo, et al.
Cardio-Oncology (London, England)
|
July 7, 2021
Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review
Shingo Kazama, Ryota Morimoto, Yuki Kimura, et al.
Cancer Science
|
May 15, 2021
Guidelines for clinical evaluation of anti-cancer drugs
Hironobu Minami, Naomi Kiyota, Shiro Kimbara, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2010
UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer
Yu Sunakawa, Wataru Ichikawa, Ken-Ichi Fujita, et al.
Biological & Pharmaceutical Bulletin
|
November 5, 2008
Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI)
Ken-ichi Fujita, Fumio Nagashima, Wataru Yamamoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 29, 2010
Delayed elimination of SN-38 in cancer patients with severe renal failure
Ken-ichi Fujita, Yu Sunakawa, Keisuke Miwa, et al.
Scientific Reports
|
February 24, 2019
An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes
Rina Sasaki, Reina Tainaka, Yuichi Ando, et al.
Journal of Geriatric Oncology
|
June 1, 2026
Six key elements for effective coordination in home-based care for older adults with cancer in Japan: A qualitative interview study
Ayumu Matsuoka, Misaki Ayata, Kiyomi Tanno, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 241) with videos related to
Sort By:
Page
of 25
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 22, 2022
[Management of Chronic Kidney Disease in Cancer Survivors]
Chihiro Kondoh, Kenji Ishikura, Satoko Ichioka, et al.
International Journal of Cancer
|
July 9, 2020
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
Yoshihiro Nishida, Hiroshi Urakawa, Robert Nakayama, et al.
Cancer Science
|
April 3, 2008
CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
Ken-ichi Fujita, Wataru Yamamoto, Shoji Endo, et al.
Cardio-Oncology (London, England)
|
July 7, 2021
Prognostic impact of immune-related adverse events on patients with and without cardiovascular disease: a retrospective review
Shingo Kazama, Ryota Morimoto, Yuki Kimura, et al.
Cancer Science
|
May 15, 2021
Guidelines for clinical evaluation of anti-cancer drugs
Hironobu Minami, Naomi Kiyota, Shiro Kimbara, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2010
UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer
Yu Sunakawa, Wataru Ichikawa, Ken-Ichi Fujita, et al.
Biological & Pharmaceutical Bulletin
|
November 5, 2008
Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI)
Ken-ichi Fujita, Fumio Nagashima, Wataru Yamamoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 29, 2010
Delayed elimination of SN-38 in cancer patients with severe renal failure
Ken-ichi Fujita, Yu Sunakawa, Keisuke Miwa, et al.
Scientific Reports
|
February 24, 2019
An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes
Rina Sasaki, Reina Tainaka, Yuichi Ando, et al.
Journal of Geriatric Oncology
|
June 1, 2026
Six key elements for effective coordination in home-based care for older adults with cancer in Japan: A qualitative interview study
Ayumu Matsuoka, Misaki Ayata, Kiyomi Tanno, et al.
Page
of 25